These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7201822)

  • 1. [Synthesis of 4-ureidooxycyclophosphamide (author's transl)].
    Niemeyer U; Scheffler G; Nonnenmacher G
    Arzneimittelforschung; 1982; 32(5):478-80. PubMed ID: 7201822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on 4-hydroperoxycyclophosphamide (NSC-181815): a simple preparation method and its application for the synthesis of a new class of "activated" sulfur-containing cyclophosphamide (NSC-26271) derivatives.
    Peter G; Wagner T; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):429-35. PubMed ID: 1277218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and identification of a stabilized derivative of aldophosphamide, a major metabolite of cyclophosphamide.
    Struck RF
    Cancer Res; 1974 Nov; 34(11):2933-5. PubMed ID: 4417999
    [No Abstract]   [Full Text] [Related]  

  • 4. Aldophosphamide: synthesis, characterization, and comparison with "Hohorst's aldophosphamide".
    Struck RF
    Cancer Treat Rep; 1976 Apr; 60(4):317-9. PubMed ID: 1277207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR spectroscopic studies of intermediary metabolites of cyclophosphamide. A comprehensive kinetic analysis of the interconversion of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and the concomitant partitioning of aldophosphamide between irreversible fragmentation and reversible conjugation pathways.
    Zon G; Ludeman SM; Brandt JA; Boyd VL; Ozkan G; Egan W; Shao KL
    J Med Chem; 1984 Apr; 27(4):466-85. PubMed ID: 6708049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides.
    Peter G; Hohorst HJ
    Cancer Chemother Pharmacol; 1979; 3(3):181-8. PubMed ID: 527208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potential virostatics. Part 3: NMR Studies in quinoxalines and s-triazolo (4,3-a) quinoxalines (author's transl)].
    Schleinitz KD; Westphal G; Köppel H; Wasicki H
    Pharmazie; 1980 Feb; 35(2):84-6. PubMed ID: 7384188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of activation of 4-hydroxycyclophosphamide.
    Borch RF; Millard JA
    J Med Chem; 1987 Feb; 30(2):427-31. PubMed ID: 3806624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-ray crystallographic studies of cyclophosphamide (NSC-26271) derivatives.
    Camerman A; Smith HW; Camerman N
    Cancer Treat Rep; 1976 Apr; 60(4):517-22. PubMed ID: 1277229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two stable Fenton oxidation products of cyclophosphamide (NSC-26271) as precursors of 4-hydroxycyclophosphamide (NSC-196562) under physiologic conditions.
    Benckhuysen C; van der Steen J; Spanjersberg EJ
    Cancer Treat Rep; 1976 Apr; 60(4):369-72. PubMed ID: 945125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution.
    Borch RF; Hoye TR; Swanson TA
    J Med Chem; 1984 Apr; 27(4):490-4. PubMed ID: 6708051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Transformation of tetrahydro-1,3-oxazine into 1,3,5-tris(3-hydroxypropyl)-hexahydro-1,3,5-triazine--a question of stability (author's transl)].
    Linde H; Oelschläger H; Czirwitzky C
    Arzneimittelforschung; 1978; 28(6):937-40. PubMed ID: 582001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic origin of cis/trans isomers of a proline-containing beta-turn model dipeptide in aqueous solution: a combined variable temperature 1H-NMR, two-dimensional 1H,1H gradient enhanced nuclear Overhauser effect spectroscopy (NOESY), one-dimensional steady-state intermolecular 13C,1H NOE, and molecular dynamics study.
    Troganis A; Gerothanassis IP; Athanassiou Z; Mavromoustakos T; Hawkes GE; Sakarellos C
    Biopolymers; 2000 Jan; 53(1):72-83. PubMed ID: 10644952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis of enantiomers of 4-ketocyclophosphamide.
    Misiura K; Pankiewicz K; Stec WJ; Jarman M
    Experientia; 1981 Mar; 37(3):216-7. PubMed ID: 7238766
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis, absolute configuration and mass spectroscopic fragmentation of the circulation analeptic cafedrine (author's transl)].
    Klingler KH; Engel J; Lüderwald I
    Arzneimittelforschung; 1980; 30(7):1060-4. PubMed ID: 7191287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NMR studies on biosubstances (author's transl)].
    Kyogoku Y
    Tanpakushitsu Kakusan Koso; 1972 Oct; 17(10):737-46. PubMed ID: 4582199
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on aromatic basic ethers with antispasmodic activity. V. Stereochemistry of 2-methyl-1-phenyl-3-piperidino-propyl phenyl ether derivatives (author's transl)].
    Yoshida A; Morita M; Ogawa S
    Yakugaku Zasshi; 1973 Sep; 93(9):1154-61. PubMed ID: 4797571
    [No Abstract]   [Full Text] [Related]  

  • 18. [Structural study of nucleic acid by NMR spectroscopy (author's transl)].
    Kainosho M
    Tanpakushitsu Kakusan Koso; 1972 Oct; 17(10):747-57. PubMed ID: 4582200
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide.
    Niemeyer U; Engel J; Scheffler G; Molge K; Sauerbier D; Weigert W
    Invest New Drugs; 1984; 2(2):133-9. PubMed ID: 6469506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [13C-NMR. Studies on ion-selective liquid membranes (author's transl)].
    Büchi R; Pretsch E; Simon W
    Helv Chim Acta; 1976 Nov; 59(7):2327-34. PubMed ID: 1017966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.